Skip to content

Adjusting to Chronic Conditions Using Education, Support, and Skills

Cognitive Behavioral Therapy in Primary Care: Treating the Medically Ill

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01149772
Acronym
ACCESS
Enrollment
302
Registered
2010-06-23
Start date
2011-02-28
Completion date
2014-10-31
Last updated
2016-02-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Obstructive Pulmonary Disease, Heart Failure, Anxiety, Depression

Keywords

Chronic Obstructive Pulmonary Disease, Heart Failure, Anxiety, Depression

Brief summary

The current study seeks to test the effectiveness of a talk-therapy intervention designed to better meet the needs of chronically ill Veterans. This project looks to recruit 450 Veterans with either chronic obstructive pulmonary disease (COPD) or heart failure (HF) who also have symptoms of worry, stress, anxiety, or sadness. Participants will be randomly put into either the talk-therapy intervention or enhanced usual care. The talk therapy intervention will be provided by VA clinicians in the primary care setting and will consist of 6 core meetings (30-45 minutes in duration) and 2 follow-up telephone meetings. Enhanced usual care participants will receive feedback regarding the assessment findings and educational materials on COPD and/or HF, depression and anxiety.

Detailed description

Diseases of the heart and circulatory system, namely, Chronic Obstructive Pulmonary Disease (COPD) and Heart Failure (HF), are two of the most common and disabling chronic diseases. Both COPD and HF account for significant disability, mortality, and healthcare costs and are associated with lower health status and more functional and social limitations than other chronic illnesses, such as hypertension and diabetes. As our population ages and life span increases, the numbers of patients with these conditions and the subsequent healthcare costs will increase dramatically. The symptoms associated with COPD and HF can significantly affect daily functioning. Physical symptoms are often linked to increased levels of psychological distress, namely, anxiety and depression, which significantly affect quality of life and functioning above and beyond the impact of the medical disease. As depression and anxiety are modifiable clinical factors, there is a potential to significantly alter patient outcomes, as well as use of healthcare services. However, focused interventions are needed, given the high risk for poor mental health treatment and underuse of mental health services in persons with COPD and HF. Unfortunately, few intervention studies have been conducted in medically ill patients with these conditions. The current project will examine whether existing VA clinicians in the primary care setting, with training and support, can effectively administer a structured Cognitive Behavioral Therapy (CBT) intervention for depressed and anxious Veterans with COPD and HF.

Interventions

BEHAVIORALACCESS

Participants received 6 treatment sessions (2 core and 4 electives). The two core modules are increasing awareness and controlling physical and emotional symptoms. After completion of the core modules the participant was able to choose elective modules from Managing Physical Health, The Power of Thoughts, Increasing Pleasant Activities, and Relaxation. Participants were required to complete the first session in person and subsequent sessions participants had the option to complete in-person or over the phone. Participants also had the option to receive 2 brief follow-up booster calls to aid in reinforcing the changes made.

Sponsors

VA Office of Research and Development
Lead SponsorFED

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Investigator)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* COPD and/or HF diagnosis; confirmation based upon medical chart review. * clinically significant symptoms for anxiety and/or depression.

Exclusion criteria

* cognitive impairment * presence of bipolar, psychotic or substance abuse disorder.

Design outcomes

Primary

MeasureTime frameDescription
Patient Health Questionnaire -9 (PHQ-9)4 month (post treatment), 8 month follow/up, and 12 month follow/upThe PHQ-9 measures an individual's level of depression. The measure is summed and ranges from 0 - 27 (individual item score range 0 - 3 per 9 items); where higher scores = worse symptoms.
Beck Anxiety Inventory (BAI)4 month (post treatment), 8 month follow/up, and 12 month follow/upThe BAI measures an individual's level of anxiety. The measure is summed and ranges from 0 - 63 (individual item score range 0 -3 per 21 items); were higher scores = worse symptoms.
Chronic Respiratory Questionnaire_Fatigue4 month (post treatment), 8 month follow/up, 12 month follow/upThe Chronic Respiratory Questionnaire (CRQ) measures the quality of life of patients with a chronic respiratory disease. This subscale measures the amount of fatigue patients experience with the condition. The CRQ is a mean score and ranges from 1 - 7, where a higher score = better health.
Chronic Respiratory Questionnaire_Mastery4 month (post treatment), 8 month follow/up, 12 month follow/upThe Chronic Respiratory Questionnaire (CRQ) measures the quality of life of patients with a chronic respiratory disease. The subscale Mastery looks at the patient's perceived control over the condition. The CRQ is a mean score and ranges from 1 - 7, where a higher score = better health
Chronic Respiratory Questionnaire_Dyspnea4 month (post treatment), 8 month follow/up, 12 month follow/upThe Chronic Respiratory Questionnaire (CRQ) measures the quality of life of patients with a chronic respiratory disease. The subscale Dyspnea looks at how much shortness of breath a patient experiences. The CRQ is a mean score and ranges from 1 - 7, where a higher score = better health.
Kansas City Cardiomyopathy Questionnaire (KCCQ)4 month (post treatment), 8 month follow/up, and 12 month follow/upThe KCCQ measures the health status of patients with congestive heart failure. The overall score is a mean score scaled from 0 - 100; where 0 represents most severe/limited functioning.

Countries

United States

Participant flow

Participants by arm

ArmCount
ACCESS
Adjusting to Chronic Conditions Using Education, Support, and Skills: Participants in this condition will receive 6 active weekly treatment sessions (2 core and 4 electives). The two core modules are increasing awareness and controlling physical and emotional symptoms. After completion of the core modules the participant will be able to choose elective modules from Managing your Physical Health, The Power of Thoughts, Increasing Pleasant Activities, and Learning How to Relax. After completion of the active treatment sessions, the participant will receive 2 brief follow-up booster calls. The follow up calls provide the opportunity for the participant to review skills learned, address any questions or difficulties, and reinforce changes made. Each active treatment session lasts 30 - 40 minutes and the booster calls last 10 - 15 minute.
180
Enhanced Usual Care
Patients in this arm receive feedback about their physical and emotional health functioning and subsequently receive usual primary care services.
122
Total302

Baseline characteristics

CharacteristicACCESSEnhanced Usual CareTotal
Age, Continuous64.9 years
STANDARD_DEVIATION 8.8
66.5 years
STANDARD_DEVIATION 8.3
65.5 years
STANDARD_DEVIATION 8.6
Beck Anxiety Inventory (BAI)21.4 units on a scale
STANDARD_DEVIATION 8.9
22.9 units on a scale
STANDARD_DEVIATION 10.7
22.0 units on a scale
STANDARD_DEVIATION 9.6
Chronic Respiratory Questionnaire_Dyspnea3.05 units on a scale
STANDARD_DEVIATION 0.95
2.90 units on a scale
STANDARD_DEVIATION 1.03
2.99 units on a scale
STANDARD_DEVIATION 0.98
Chronic Respiratory Questionnaire_Fatigue2.63 units on a scale
STANDARD_DEVIATION 0.9
2.43 units on a scale
STANDARD_DEVIATION 0.97
2.55 units on a scale
STANDARD_DEVIATION 0.93
Chronic Respiratory Questionnaire_Mastery3.63 units on a scale
STANDARD_DEVIATION 1.03
3.48 units on a scale
STANDARD_DEVIATION 1.16
3.57 units on a scale
STANDARD_DEVIATION 1.08
Kansas City Cardiomyopathy Questionnaire (KCCQ)36.93 units on a scale
STANDARD_DEVIATION 14.94
37.03 units on a scale
STANDARD_DEVIATION 19.36
36.97 units on a scale
STANDARD_DEVIATION 16.81
Patient Health Questionnaire (PHQ9)13.8 units on a scale
STANDARD_DEVIATION 4.6
14.9 units on a scale
STANDARD_DEVIATION 5
14.2 units on a scale
STANDARD_DEVIATION 4.8
Region of Enrollment
United States
180 participants122 participants302 participants
Sex: Female, Male
Female
12 Participants6 Participants18 Participants
Sex: Female, Male
Male
168 Participants116 Participants284 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
— / —— / —
other
Total, other adverse events
57 / 18052 / 122
serious
Total, serious adverse events
8 / 1809 / 122

Outcome results

Primary

Beck Anxiety Inventory (BAI)

The BAI measures an individual's level of anxiety. The measure is summed and ranges from 0 - 63 (individual item score range 0 -3 per 21 items); were higher scores = worse symptoms.

Time frame: 4 month (post treatment), 8 month follow/up, and 12 month follow/up

ArmMeasureGroupValue (MEAN)Dispersion
ACCESSBeck Anxiety Inventory (BAI)4 Month17.42 units on a scaleStandard Deviation 8.52
ACCESSBeck Anxiety Inventory (BAI)8 Month16.85 units on a scaleStandard Deviation 9.27
ACCESSBeck Anxiety Inventory (BAI)12 Month16.97 units on a scaleStandard Deviation 7.91
Enhanced Usual CareBeck Anxiety Inventory (BAI)12 Month21.19 units on a scaleStandard Deviation 11.4
Enhanced Usual CareBeck Anxiety Inventory (BAI)4 Month22.67 units on a scaleStandard Deviation 11.18
Enhanced Usual CareBeck Anxiety Inventory (BAI)8 Month21.59 units on a scaleStandard Deviation 11.41
Primary

Chronic Respiratory Questionnaire_Dyspnea

The Chronic Respiratory Questionnaire (CRQ) measures the quality of life of patients with a chronic respiratory disease. The subscale Dyspnea looks at how much shortness of breath a patient experiences. The CRQ is a mean score and ranges from 1 - 7, where a higher score = better health.

Time frame: 4 month (post treatment), 8 month follow/up, 12 month follow/up

Population: Only patients experiencing chronic lung problems (Chronic Obstructive Pulmonary Disease, emphysema, bronchitis, asthma) completed this assessment.

ArmMeasureGroupValue (MEAN)Dispersion
ACCESSChronic Respiratory Questionnaire_Dyspnea4 month3.37 units on a scaleStandard Deviation 1.15
ACCESSChronic Respiratory Questionnaire_Dyspnea8 month3.27 units on a scaleStandard Deviation 1.02
ACCESSChronic Respiratory Questionnaire_Dyspnea12 month3.07 units on a scaleStandard Deviation 0.99
Enhanced Usual CareChronic Respiratory Questionnaire_Dyspnea4 month2.94 units on a scaleStandard Deviation 0.98
Enhanced Usual CareChronic Respiratory Questionnaire_Dyspnea8 month3.03 units on a scaleStandard Deviation 0.89
Enhanced Usual CareChronic Respiratory Questionnaire_Dyspnea12 month3.11 units on a scaleStandard Deviation 1.05
Primary

Chronic Respiratory Questionnaire_Fatigue

The Chronic Respiratory Questionnaire (CRQ) measures the quality of life of patients with a chronic respiratory disease. This subscale measures the amount of fatigue patients experience with the condition. The CRQ is a mean score and ranges from 1 - 7, where a higher score = better health.

Time frame: 4 month (post treatment), 8 month follow/up, 12 month follow/up

Population: Only patients experiencing chronic lung problems (COPD, emphysema, bronchitis, asthma) completed this assessment.

ArmMeasureGroupValue (MEAN)Dispersion
ACCESSChronic Respiratory Questionnaire_Fatigue4 month3.20 units on a scaleStandard Deviation 1.08
ACCESSChronic Respiratory Questionnaire_Fatigue8 month3.11 units on a scaleStandard Deviation 1.09
ACCESSChronic Respiratory Questionnaire_Fatigue12 month3.05 units on a scaleStandard Deviation 1.06
Enhanced Usual CareChronic Respiratory Questionnaire_Fatigue4 month2.58 units on a scaleStandard Deviation 1.08
Enhanced Usual CareChronic Respiratory Questionnaire_Fatigue8 month2.68 units on a scaleStandard Deviation 1.01
Enhanced Usual CareChronic Respiratory Questionnaire_Fatigue12 month2.77 units on a scaleStandard Deviation 1.15
Primary

Chronic Respiratory Questionnaire_Mastery

The Chronic Respiratory Questionnaire (CRQ) measures the quality of life of patients with a chronic respiratory disease. The subscale Mastery looks at the patient's perceived control over the condition. The CRQ is a mean score and ranges from 1 - 7, where a higher score = better health

Time frame: 4 month (post treatment), 8 month follow/up, 12 month follow/up

Population: Only patients experiencing chronic lung problems (COPD, emphysema, bronchitis, asthma) completed this assessment.

ArmMeasureGroupValue (MEAN)Dispersion
ACCESSChronic Respiratory Questionnaire_Mastery4 month4.25 units on a scaleStandard Deviation 1.14
ACCESSChronic Respiratory Questionnaire_Mastery8 month4.20 units on a scaleStandard Deviation 1.2
ACCESSChronic Respiratory Questionnaire_Mastery12 month3.96 units on a scaleStandard Deviation 1.11
Enhanced Usual CareChronic Respiratory Questionnaire_Mastery4 month3.51 units on a scaleStandard Deviation 1.19
Enhanced Usual CareChronic Respiratory Questionnaire_Mastery8 month3.45 units on a scaleStandard Deviation 1.22
Enhanced Usual CareChronic Respiratory Questionnaire_Mastery12 month3.62 units on a scaleStandard Deviation 1.28
Primary

Kansas City Cardiomyopathy Questionnaire (KCCQ)

The KCCQ measures the health status of patients with congestive heart failure. The overall score is a mean score scaled from 0 - 100; where 0 represents most severe/limited functioning.

Time frame: 4 month (post treatment), 8 month follow/up, and 12 month follow/up

Population: Only patients randomized for heart failure was required to complete the assessment. There were fewer patients randomized for congestive heart failure (CHF) as compared to COPD.

ArmMeasureGroupValue (MEAN)Dispersion
ACCESSKansas City Cardiomyopathy Questionnaire (KCCQ)4 month40.25 units on a scaleStandard Deviation 15.12
ACCESSKansas City Cardiomyopathy Questionnaire (KCCQ)8 month41.34 units on a scaleStandard Deviation 19.89
ACCESSKansas City Cardiomyopathy Questionnaire (KCCQ)12 month42.89 units on a scaleStandard Deviation 18.3
Enhanced Usual CareKansas City Cardiomyopathy Questionnaire (KCCQ)4 month41.81 units on a scaleStandard Deviation 19.21
Enhanced Usual CareKansas City Cardiomyopathy Questionnaire (KCCQ)8 month36.23 units on a scaleStandard Deviation 18.21
Enhanced Usual CareKansas City Cardiomyopathy Questionnaire (KCCQ)12 month41.68 units on a scaleStandard Deviation 20.81
Primary

Patient Health Questionnaire -9 (PHQ-9)

The PHQ-9 measures an individual's level of depression. The measure is summed and ranges from 0 - 27 (individual item score range 0 - 3 per 9 items); where higher scores = worse symptoms.

Time frame: 4 month (post treatment), 8 month follow/up, and 12 month follow/up

ArmMeasureGroupValue (MEAN)Dispersion
ACCESSPatient Health Questionnaire -9 (PHQ-9)4 Month10.35 units on a scaleStandard Deviation 5.08
ACCESSPatient Health Questionnaire -9 (PHQ-9)8 Month10.32 units on a scaleStandard Deviation 5.48
ACCESSPatient Health Questionnaire -9 (PHQ-9)12 Month10.59 units on a scaleStandard Deviation 5.07
Enhanced Usual CarePatient Health Questionnaire -9 (PHQ-9)4 Month13.28 units on a scaleStandard Deviation 5.82
Enhanced Usual CarePatient Health Questionnaire -9 (PHQ-9)8 Month13.49 units on a scaleStandard Deviation 6.05
Enhanced Usual CarePatient Health Questionnaire -9 (PHQ-9)12 Month13.22 units on a scaleStandard Deviation 6.38

Source: ClinicalTrials.gov · Data processed: Mar 26, 2026